MomcilovicDReznakovaBBosseFBegrichCBernhardtCHamikoMet al
[6] Preclinical studies in animal models suggest that GLP-1 receptor activation may: Promote neuroplasticity and neurogenesis (formation of new neurons) in the hippocampus, a region often showing reduced volume in depression Modulate neurotransmitter systems , particularly dopamine and serotonin pathways involved in mood regulation and reward processing Reduce neuroinflammation , which is increasingly recognised as contributing to depressive disorders Enhance brain-derived neurotrophic factor (BDNF) expression, a protein crucial for neuronal health and resilience Metabolic improvements associated with GLP-1 therapy may also contribute indirectly to mood benefits
Wool, nylon, and polyester fabrics can cause irritation, overheating, and sweating
So I don't want people to despair that if they can't access the GLP-1s via the Medicaid Part D program or another program, there are other ways to receive data-driven obesity treatment
In lab models, DSIP potentiated GABA-activated currents and affected excitatory signaling, which aligns with its studied calming/sleep-related effects
Impaired Cellular Repair: Reduced sirtuin activity due to NAD+ decline can accelerate cellular aging and increase vulnerability to various health issues
